Category: Inflammation

  • “Smart” drug targets site-specific inflammation

    “Smart” drug targets site-specific inflammation

    Ben-Gurion University‘s Peleg Rider has developed a drug that targets inflammation in a site-specific manner.  This could improve the body’s  ability to fight infection and reduce side effects. When injected, it is a non-active drug.  A localized site with excessive inflammation will activate it.  Other anti-inflammatory agents inhibit inflammatory processes throughout the body, including sites of…